Form 4 for STLN Starling Oncology, Inc.
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-21 · accession 0001628280-23-039913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-22 | 2023-11-21 | STLN | Hively Brad | Dir | D - Sale to Iss | $2.19 | -25.9K | 671.2K | -4% | -$56.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-11-21 | D | D | 25,867 | $2.19 | 671,198 | D | — | — |